Brief: Vaccitech Acquires Avidea Technologies To Expand Product Pipeline And Strengthen Scientific Leadership In Immunotherapies And Vaccines
13/12/2021 22:38
Dec 13 (Reuters) - Vaccitech PLC VACC.O :
* VACCITECH ACQUIRES AVIDEA TECHNOLOGIES TO EXPAND PRODUCT
PIPELINE AND STRENGTHEN SCIENTIFIC LEADERSHIP IN IMMUNOTHERAPIES
AND VACCINES
* VACCITECH PLC - CONSIDERATION TO AVIDEA'S EXISTING
SHAREHOLDERS
IS $40 MILLION
Source text for Eikon: ID:nGNX7w8htN
Further company coverage: VACC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Barinthus Biotherapeutics
See all newsBrief: Barinthus Bio Provides Update On Proposed Combination With Clywedog Therapeutics
Brief: Barinthus Biotherapeutics PLC Appoints Douglas Swirsky As CFO And Principal Accounting Officer Effective May 1, 2026
Brief: Barinthus Bio Announces Update On Phase 1 AVALON Clinical Trial Of VTP-1000 For The Treatment Of Celiac Disease
Brief: Barinthus Bio Reports Second Quarter 2025 Financial Results And Updates On Corporate Developments
Gemma Brown Terminated As CFO Effective April 30, 2025 - SEC Filing